Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to GeneFluidics, Inc. in May, 2019 for $966,760.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44HD084033-04 | Phase II | 966,760 | May 15, 2019 | |||||||
A SBIR Phase I contract was awarded to GeneFluidics, Inc. in August, 2016 for $1,989,569.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2SB1AI088756-06 | Phase I | 1,989,569 | August 1, 2016 | |||||||
A SBIR Phase II contract was awarded to GeneFluidics, Inc. in August, 2016 for $2,989,569.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2SB1AI088756-06 | Phase II | 2,989,569 | August 1, 2016 | |||||||
A SBIR Phase II contract was awarded to GeneFluidics, Inc. in July, 2016 for $1,495,579.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44HD084033-02 | Phase II | 1,495,579 | July 1, 2016 | |||||||
A SBIR Phase I contract was awarded to GeneFluidics, Inc. in July, 2015 for $223,629.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA199211-01 | Phase I | 223,629 | July 6, 2015 | |||||||
A SBIR Phase I contract was awarded to GeneFluidics, Inc. in May, 2015 for $224,468.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44HD084033-01 | Phase I | 224,468 | May 1, 2015 | |||||||
A SBIR Phase I contract was awarded to GeneFluidics, Inc. for $97,205.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI091213-01 | Phase I | 97,205 | ||||||||
A SBIR Phase I contract was awarded to GeneFluidics, Inc. for $700,467.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI088756-01 | Phase I | 700,467 | ||||||||
A SBIR Phase I contract was awarded to GeneFluidics, Inc. for $128,762.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA096065-01 | Phase I | 128,762 | ||||||||
A SBIR Phase I contract was awarded to GeneFluidics, Inc. for $434,330.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD065303-01 | Phase I | 434,330 | ||||||||
A SBIR Phase II contract was awarded to GeneFluidics, Inc. for $2,973,776.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI088756-03 | Phase II | 2,973,776 |